Noncanonical TGF-β pathways, mTORC1 and Abl, in renal interstitial fibrogenesis
- 1 January 2010
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 298 (1), F142-F149
- https://doi.org/10.1152/ajprenal.00320.2009
Abstract
Renal interstitial fibrosis is a major determinant of renal failure in the majority of chronic renal diseases. Transforming growth factor-β (TGF-β) is the single most important cytokine promoting renal fibrogenesis. Recent in vitro studies identified novel non-smad TGF-β targets including p21-activated kinase-2 (PAK2), the abelson nonreceptor tyrosine kinase (c-Abl), and the mammalian target of rapamycin (mTOR) that are activated by TGF-β in mesenchymal cells, specifically in fibroblasts but less in epithelial cells. In the present studies, we show that non-smad effectors of TGF-β including PAK2, c-Abl, Akt, tuberin (TSC2), and mTOR are activated in experimental unilateral obstructive nephropathy in rats. Treatment with c-Abl or mTOR inhibitors, imatinib mesylate and rapamycin, respectively, each blocks noncanonical (non-smad) TGF-β pathways in the kidney in vivo and diminishes the number of interstitial fibroblasts and myofibroblasts as well as the interstitial accumulation of extracellular matrix proteins. These findings indicate that noncanonical TGF-β pathways are activated during the early and rapid renal fibrogenesis of obstructive nephropathy. Moreover, the current findings suggest that combined inhibition of key regulators of these non-smad TGF-β pathways even in dose-sparing protocols are effective treatments in renal fibrogenesis.Keywords
This publication has 23 references indexed in Scilit:
- Distinct Roles for Mammalian Target of Rapamycin Complexes in the Fibroblast Response to Transforming Growth Factor-βCancer Research, 2008
- The TSC1-TSC2 Complex Is Required for Proper Activation of mTOR Complex 2Molecular and Cellular Biology, 2008
- Transforming Growth Factor β Activation of c-Abl Is Independent of Receptor Internalization and Regulated by Phosphatidylinositol 3-Kinase and PAK2 in Mesenchymal CulturesPublished by Elsevier BV ,2006
- A novel mechanism for Bcr-Abl action: Bcr-Abl-mediated induction of the eIF4F translation initiation complex and mRNA translationOncogene, 2006
- Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosisKidney International, 2006
- Smad3 is key to TGF-β-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasisCytokine & Growth Factor Reviews, 2006
- TOR Signaling in Growth and MetabolismCell, 2006
- Smad3: A Key Player in Pathogenetic Mechanisms Dependent on TGF‐βAnnals of the New York Academy of Sciences, 2003
- Increased expression of TGF-β1 but not of its receptors contributes to human obstructive nephropathyKidney International, 1999
- Sustained expression of TGF-β1 underlies development of progressive kidney fibrosisKidney International, 1994